Pfizer-BioNTech vaccine shot stops covid spread – Israeli Study

The Pfizer/ BioNTech jointly developed COVID-19 vaccine appeared to prevent the vast majority of recipients in Israel from being infected, Bloomberg reports after seeing a copy of a draft publication that was posted on Twitter and confirmed by a person familiar with the latest Israeli study.
Key takeaways
“The vaccine, which is being rolled out in a national immunization program that began Dec. 20, was 89.4% effective at preventing laboratory-confirmed infections.”
“If confirmed, the early results on lab-tested infections are encouraging because they indicate the vaccine may also prevent asymptomatic carriers from spreading the virus that causes Covid-19.“
“Israeli authorities on Saturday said the Pfizer-BioNTech shot was 99% effective at preventing deaths from the virus.”
Market reaction
The risk sentiment remains buoyed amid progress made in curbing the coronavirus spread globally and upbeat vaccine results.
The S&P 500 futures add 0.11% on the day to trade just above 3,900 while the US dollar index attempts a recovery from multi-day lows, still in the red around 90.30.
Author

Dhwani Mehta
FXStreet
Residing in Mumbai (India), Dhwani is a Senior Analyst and Manager of the Asian session at FXStreet. She has over 10 years of experience in analyzing and covering the global financial markets, with specialization in Forex and commodities markets.

















